Dietary modification alone is insufficient for treating established deficiency but plays a supportive role in prevention
Drinking alcohol while on treatment may reduce the overall benefit of therapy and can also strain the liver and nervous system
When you see a dose range cited in research literature, treat it as a description of what a specific trial protocol tested not a instruction to replicate without independent verification of your own protocol and research context
Always follow your clinicians specific instructions
Relevant Research Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomised controlled trials Retatrutide for the treatment of obesity, obstructive sleep apnea, and knee osteoarthritis: rationale and design of the TRIUMPH registrational clinical trials Retatrutidea game changer in obesity pharmacotherapy Unleashing the power of retatrutide: a possible triumph over obesity Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomised phase 2a trial Retatrutide in type 2 diabetes mellitus and obesity: an overview
Always consult with a qualified healthcare professional before beginning any new wellness protocol
